I’m about to piss off every anticoagulation clinic, haematology group, and pharmaceutical company in America.
Because what I’m about to share could cost them MILLIONS in lost revenue.
But I don’t care anymore.
After watching my patient Colm write “THEY SAID I WAS FINE AND SENT ME HOME WITH NOTHING” in all caps on his follow-up survey…
After seeing him describe the last day of his course — six months of tablets, a handshake, and a sentence that has haunted him ever since: “you’re done, we’ll just monitor you”…
After watching him walk out of that building with nothing in his hands and a four-in-ten chance sitting on his shoulders, and nobody telling him what the next ten years actually looked like…
I knew the system had failed him.
So I went rogue and discovered something that changed everything.
And if the tablets have stopped — if you still check your leg in the morning without quite admitting that’s what you’re doing, if nobody has offered you anything since the day they discharged you…
The next 5 minutes could be the most important of your life.
My name is Dr. Irene Halvorsen. I’ve been a licensed haematologist for 23 years.
I serve as the Medical Director of Meridian Vascular Research, an independent organization dedicated to finding natural cures the medical industry ignores.
And I’m about to expose the dirty secret that leaves hundreds of thousands of clot survivors monitored, un-helped and quietly terrified… while the medical industry laughs all the way to the bank.
But first, let me tell you about the evening that changed everything…
I was in my office late on a Thursday night. Going through patient surveys from the week.
Most of them were pretty standard. “Course completed.” “No further episodes.”
Then I got to Colm’s. And my stomach dropped.
He’d written in all caps: “THEY SAID I WAS FINE AND SENT ME HOME WITH NOTHING.”
Not “I have some questions about my follow-up.” Not “I’d like to discuss recurrence.”
“THEY SAID I WAS FINE AND SENT ME HOME WITH NOTHING.”
He described the night it happened. A calf that felt like a pulled muscle for two days, then a drive to an emergency department he nearly didn’t make, then a scan, then a word.
He described the part nobody writes about: how completely it rearranges you. How he lay awake for the first three weeks doing the arithmetic on what would have happened if he’d gone to bed instead of getting in the car.
Then six months of tablets. And on the last day, a conversation that took under four minutes.
“You’re done. We’ll just monitor you.”
He wrote that he asked what monitoring meant and was told to come back if it happened again.
He wrote that he had been checking his left calf every single morning for eleven months and had never told his wife he was doing it.
He was 51 years old. And he had been discharged from the most frightening thing that ever happened to him with a handshake and no plan.
And here’s what killed me…
Colm had done EVERYTHING right. Took every tablet. Made every appointment. Wore the stockings. Walked every day. Lost weight. Stopped the long drives without breaking them up.
All of it. And on the last day he was handed the same thing everybody is handed: nothing.
His GP? Suggested a baby aspirin. Not unreasonable, and not remotely equal to what he had just been through.
His specialist? When Colm asked what he should actually be doing, he was told they would monitor him.
Monitor you.
As if watching were a plan.
And here is the number nobody said out loud to him, which I am going to say out loud to you now.
? Roughly 41 out of every 100 people who have had one clot will have another within ten years. And the risk is steepest in the first year after the anticoagulant stops.
He was told he was fine. He was, statistically, at the single most dangerous point of the entire decade.
I sat there staring at that survey for twenty minutes. And something inside me snapped.
I wasn’t gonna let this keep happening. Not to Colm. Not to anyone else.
For the next 3 months, I lived like a woman possessed.
I devoured every paper on recurrence and fibrinolysis I could find. Called researchers at Johns Hopkins, the Cleveland Clinic, and the Mayo Clinic. Flew to conferences in Germany and Japan. Spent $11,000 of my own money on medical journals, insider reports, and access to restricted research databases.
My husband thought I was losing my mind. Maybe I was. But I didn’t care.
And what I found… genuinely made me want to punch a hole through my computer screen.
Your blood thinner was never what you thought it was. And nobody corrected you.
Here’s what they don’t want you to know, and I want to be very careful here because this is not an attack on your medication.
?? An anticoagulant is a brake. It is not a broom.
It does one job and it does it superbly: it makes it much harder for your blood to form new clot. That is why you took it. That is why you are alive. I prescribe these drugs every week of my working life and I would put you on one again tomorrow if you needed it.
But read the sentence again, because everything follows from it.
It stops new mesh forming. It does not sweep out the mesh that is already there.
That was never its job. It was never designed for that. And in six months of taking it, almost nobody is ever told the difference — because in the acute phase the difference does not matter.
It matters enormously on the day the tablets stop.
Think about what that day actually is. The brake comes off. And whatever mesh is still in there — the residue in the vein wall, the webbing that organised and stayed — is still exactly where it was.
And your own clearing system, the one that is supposed to remove it, has a problem of its own.
There is mesh left over in you, and the thing that was supposed to sweep it never came. And I don’t mean that metaphorically.
When a clot forms, it is made of fibrin — a stringy protein mesh that traps blood cells and sets. That is what a clot physically is.
Your body has a crew for dismantling it, an enzyme called plasmin. In a healthy young system, plasmin arrives, breaks the mesh into fragments, and carries them away. That process is why a D-dimer test exists at all — D-dimer is one of those fragments.
But here is what actually happens after a real clot, and it is not what most people picture.
The clot does not simply dissolve and vanish. A portion of it organises. The mesh cross-links, tightens, becomes part of the vein wall, and stops shedding fragments.
? Which means your D-dimer can come down not because the mesh has gone, but because it has settled in and stopped falling apart. A quieter number is not the same as a clear vein, and nobody explains that distinction on discharge day.
Now the part that decides your next ten years.
Your body also produces a substance called PAI-1, whose entire job is to put the brakes on your own clearing crew. It rises with age, with inflammation, with excess weight, and it stays elevated for a long time after an event like yours.
So picture the position you are actually in on the day your tablets stop:
This is “Leftover Mesh Syndrome.”
And it explains EVERYTHING.
And the system treats the year after discharge as somebody else’s problem.
You know why? Because a survivor who has finished his course is a closed file. He is a success. He does not generate an appointment.
He’s just… monitored. Discharged. Congratulated.
Until he isn’t.
Until a Tuesday afternoon when something moves… and suddenly you are back in the same emergency department, and this time it may not be a leg.
They don’t want to fill that gap. Because the gap has no billing code.
It’s genius, really. If you’re a sociopath who sees human suffering as a revenue stream.
Remember Colm? The man who wrote “THEY SENT ME HOME WITH NOTHING”?
Four months after I applied these findings to his care, he did something he had not managed in almost a year.
He went a whole week without checking his calf.
Truly life-changing.
We used a method I now call “Clear and Sweep.” ? The logic is one line: your thinner handled the brake. Nothing has ever handled the broom.
To work on what a finished course leaves behind, you need to do THREE things at the same time:
Miss even ONE of these steps, and you’re wasting your time.
That’s why the anticoagulant ended without solving this. (It was a brake. It did its job. Brakes do not sweep.)
That’s why the baby aspirin feels thin. (A milder brake.)
That’s why the compression stockings help your symptoms and not your odds. (They manage pressure in the leg. They do not touch what is in the vein.)
That’s why monitoring changes nothing. (It is a camera, not a treatment.)
You need all three. At the same time. Working together.
A Triple-Action Clear, Calm, and Lock. And that’s exactly what this formula delivers.
Apply Discount & Check Availability90-day money-back guarantee · Ships from the USA
After Colm’s results, word spread fast.
My colleague Petra… a vascular ultrasound technologist of nineteen years… caught me in the corridor one evening.
“Whatever you did for Colm. I need it. NOW.”
Petra was 44. Fit. A provoked clot after knee surgery, three years earlier.
And a course that had ended two years ago with the same four-minute conversation.
The worst part? She was the person who does the scans. ? She has spent nineteen years watching residual mesh sit in other people’s veins on a screen and writing the word *chronic* in her reports. She knew perfectly well that a finished course does not mean an empty vein. Nobody had ever suggested there was anything to do about it.
She’d tried everything available to her. Stockings. Walking. Keeping her weight down. A baby aspirin she was ambivalent about.
I gave her a bottle, after confirming the one thing that matters: her course had ended and she was on nothing.
Ten weeks later she texted me. “Irene. I scanned a man today and realised I haven’t checked my own leg in a fortnight.”
She rang me from her car, and I could hear it.
Not about a number.
Because for two years the most accurate word for her condition had been vigilance, and she had just noticed it letting go.
Within 72 hours, I had people tracking me down. Survivors a year out with nothing in their hands. People who check a limb every morning and have never said so. Men and women who were told they were fine at exactly the point the data says they were most at risk…
Every. Single. One. Finally had something to do.
Not “reassured” better. Not “monitored” better.
ACTUALLY DOING SOMETHING.
That’s when the threats started.
First, it was “friendly” warnings.
A colleague I’d known for over a decade pulled me aside at a conference: “Irene, you’re going to have patients coming off anticoagulation because of this. You should stop before someone gets hurt.”
Which would be a fair concern if it were what I was saying — and it is the exact opposite of what I have said on every page, in every talk, and at the top of this one. Translation: Stop pointing at the year we do nothing.
Then came the cease and desist letters. Three law firms. All representing “concerned medical professionals.” Claiming I was “practicing outside my scope.”
The final straw? A pharmaceutical rep I’d worked with for 8 years… stopped returning my calls.
“Sorry Irene, corporate told me to focus on other accounts. Nothing personal.”
They wanted me gone because I’d created something that could make their entire business model obsolete.
A simple daily capsule that:
But here’s what those medical industry vultures didn’t count on…
I’d already partnered with a small team of formulators who believed in what we were doing. People who’d watched their own families get sent home with a handshake.
And together, we’d turned my clinical discovery into something anyone could access.
It’s called Noverly Nattokinase 10,000 FU.
Nattokinase is an enzyme produced when Bacillus subtilis natto ferments soybeans. In 1980 a researcher named Hiroyuki Sumi screened 173 foods looking for one that would dissolve a human clot. 172 failed. He dripped natto onto artificial thrombus, warmed it to body temperature, and went home — and came back to find the clot gone in about 18 hours.
? That is the distinction that matters for you: it breaks fibrin down. It does not simply prevent more of it. It is doing the job your own plasmin is being suppressed from doing.
?? And here is the honest state of the evidence, including the part against us. There is a randomised trial — sometimes called the NAPS study — that found no meaningful effect. It ran in healthy low-risk volunteers with nothing to clear. Meanwhile a study of 1,062 participants found 10,800 FU daily improved arterial measures over twelve months, while 3,600 FU did nothing at all. Take both seriously: the dose has to be clinical, and the person has to actually have something to work on. You are not a healthy low-risk volunteer. That is the entire reason this page is addressed to you and not to the general public.
These work the inflammation that keeps your own sweeper suppressed. Different job from the enzyme entirely.
K2-MK7 routes freed calcium into bone rather than the vessel wall. CoQ10 supports the cells lining those vessels.
?? One specific note, because you above all people need it: vitamin K2 directly opposes warfarin. If you are on warfarin this product is not for you, full stop — and that is true of the K2 quite separately from the enzyme.
After 12 hours? You won’t feel anything. That’s the point.
You have never once felt this condition coming. That is exactly why it frightens you, and any product promising you a sensation is lying.
? So here is what I ask every patient to do, and it is not a supplement instruction:
Ask your doctor one question: “Given my clot was unprovoked, am I actually a candidate for extended anticoagulation?”
For a meaningful number of people the honest answer is yes, and it was never properly discussed. If that is you, take the extended course and do not take this. I would rather you leave this page with a prescription than with a bottle.
Three weeks before anything moves. Eight before it’s worth judging.
In the last 18 months, over 10,000 people have used Noverly Nattokinase 10,000 FU for circulation support after a finished course.
But my favourite stat? Our refund rate is 0.4%. That’s FOUR people per thousand.
Don’t take my word for it. Here’s what real people are saying:
The system LOVES that structure.
You know why? Because the acute episode is enormously billable and the year afterwards is free. Your discharge was not a medical judgement that you were safe. It was the end of a protocol.
Nobody makes money on the year you were told to wait.
? And the villain here is not your medication, your haematologist, or the drug company. It is a pathway that ends at exactly the point the data says the risk peaks — and then calls that ending *reassurance.*
A clinical-dose nattokinase formula with all seven actives should cost $200 a bottle.
The regular price is $49.99. Less than one follow-up appointment.
But that’s not what you’ll pay today.
Remember those cease and desist letters? The threats? The blacklisting?
Well, I just got word that a major pharmaceutical company is trying to patent-block our formula.
They can’t copy it. They can’t buy me out (I told them to pound sand). So now they’re trying to bury us in legal fees and regulatory red tape.
My response? I’m putting our entire inventory on sale.
Less than ONE follow-up appointment. For the only formula aimed at the broom instead of the brake.
Why would I do this? Because every survivor who finally has something to do is living proof the pathway failed them.
This discount won’t last forever. Not because I’m playing marketing games.
But because nattokinase cannot be manufactured. It has to be fermented.
The enzyme does not exist in the soybean. It is produced by Bacillus subtilis natto during a fermentation that cannot be rushed, at a temperature that cannot be raised — heat destroys the enzyme. Then it is assayed to confirm it hits 10,000 fibrinolytic units, because a great many bottles do not.
?? FU measures ACTIVITY, not weight — and in that 1,062-person study, 3,600 FU did nothing.
And here’s the thing… Every month you wait is another month you’re:
Look, I get it. You have been handed nothing for a year and you have learned to expect nothing.
Try Noverly Nattokinase for 90 days. One capsule every morning.
And if at the end of it you don’t feel you have finally been doing something instead of waiting…
I’ll refund every penny. No forms. No questions. Email support@noverly.shop and say “refund.”
Our refund rate is 0.4%. That’s FOUR people per thousand. You can reach a human at (657) 276-6729.
Eleven months ago Colm was checking his calf every morning and telling nobody.
He’d done everything. Every tablet. Every appointment. The stockings, the walking, the weight. And on the last day: a handshake, and a sentence about monitoring.
Today? He sent me a photograph of a wall calendar where he had been marking the mornings he checked. The marks run in a dense unbroken column… and then, in the last fortnight, they stop.
The only thing that changed? Somebody finally explained that his tablets were a brake, that nothing had ever been the broom, and gave him the broom.
You can keep being monitored. Keep checking the leg. Keep sitting inside the steepest year of the decade having been told you were fine.
Or you can do what Colm did. What Petra did. What Wendell did.
Sweep what the brake left behind.
$49.99. Less than one follow-up appointment.
And understand exactly what I am and am not telling you. I am not telling you this prevents a clot. It is not a medicine and it is not a substitute for one. I am not telling you to stop anything, and if you are on a thinner this is not for you at all. What I am telling you is that your treatment was a brake, the broom was never issued, and the year they leave you alone is the year the data says matters most.
You were not being paranoid.
You were correctly noticing that nobody had given you anything to do.
Later doesn’t exist inside the steepest year. Later is another morning checking a limb. Later is the discount expiring.
LIMITED TIME READER-ONLY SPECIAL: Ordering now makes you eligible for the reader discount on Noverly Nattokinase 10,000 FU. Only available here.
This offer expires soon.
With hope,
Dr. Irene Halvorsen, MD
Meridian Vascular Research
P.S. Colm sent me a photo of a wall calendar. A dense column of marks for every morning he checked his leg — and then, in the last fortnight, nothing. That is not a clinical endpoint. It is the one he cared about.
P.P.S. Roughly 41 in 100 people who have had one clot have another within ten years, and the risk is steepest in the first year after the anticoagulant stops. You were discharged into that year and told you were fine. Both things are true at once, and nobody said the second one out loud.
P.P.P.S. ? And once more, because I would rather lose the sale: if you are still on a blood thinner, do not order this, and do not come off your medication. Come back if your doctor ends the course.
90-day money-back guarantee · Ships from the USA